Granulins rescue inflammation, lysosome dysfunction, lipofuscin, and neuropathology in a mouse model of progranulin deficiency
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Jessica Root und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, Emory University, School of Medicine, Atlanta, GA 30322, USA; Center for Neurodegenerative Disease, …. Hauptthemen laut MEDLINE: Progranulins, Lysosomes, Granulins, Disease Models, Animal. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Progranulin (PGRN) deficiency is linked to neurodegenerative diseases, including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. Proper PGRN levels are critical for brain health; however, the function of PGRN is unclear. PGRN is composed of 7.5 repeat domains, called granulins, and processed into granulins inside the lysosome. PGRN is beneficial for neuronal health, but the role of individual granulins is controversial and unclear. We find that the expression of single granulins broadly rescues disease pathology in Grn-/- mice. Adeno-associated virus (AAV)-mediated expression of human granulin-2/F, granulin-4/A, or PGRN in Grn-/- mouse brain ameliorates dysregulated lysosomal proteins and lipids, microgliosis, and lipofuscinosis. Mechanistically, granulins localize to lysosomes in Grn-/- mouse brains or fibroblasts. These data support the hypothesis that PGRN is a precursor to granulins, which share a beneficial function inside the lysosome to maintain lipid and protein homeostasis to prevent neurodegeneration. Thus, granulins are potential therapeutics to treat FTD-GRN and related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Chemical Biology, Emory University, School of Medicine, Atlanta, GA 30322, USA; Center for Neurodegenerative Disease, Emory University, School of Medicine, Atlanta, GA 30322, USA.
- Arkuda Therapeutics, 200 Arsenal Yards Blvd., Suite 220, Watertown, MA 02472, USA.
- Department of Pharmacology and Chemical Biology, Emory University, School of Medicine, Atlanta, GA 30322, USA; Center for Neurodegenerative Disease, Emory University, School of Medicine, Atlanta, GA 30322, USA; Departme…
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- NCI NIH HHS
- National Cancer Institute
- National Institute on Aging
- School of Medicine, Emory University
- BrightFocus Foundation
- Alzheimer's Drug Discovery Foundation
Zitieren
APA
Root, J., Mendsaikhan, A., Taylor, G., Merino, P., Nandy, S., Wang, M., Araujo, L. T., Ryu, D., Holler, C., Thompson, B. M., Astarita, G., Blain, J. F., & Kukar, T. (2024). Granulins rescue inflammation, lysosome dysfunction, lipofuscin, and neuropathology in a mouse model of progranulin deficiency. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114985
Vancouver
Root J, Mendsaikhan A, Taylor G, Merino P, Nandy S, Wang M, et al. Granulins rescue inflammation, lysosome dysfunction, lipofuscin, and neuropathology in a mouse model of progranulin deficiency. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114985
BibTeX
@article{Root2024,
author = {Root, Jessica and Mendsaikhan, Anarmaa and Taylor, Georgia and Merino, Paola and Nandy, Srijita and Wang, Minzheng and Araujo, Ludmilla Troiano and Ryu, Danny and Holler, Christopher and Thompson, Bonne M and Astarita, Giuseppe and Blain, Jean-François and Kukar, Thomas},
title = {Granulins rescue inflammation, lysosome dysfunction, lipofuscin, and neuropathology in a mouse model of progranulin deficiency},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114985}
}
EUVIMED